Padma Ladda | Pharmacology | Best Research Article Award

Best Research Article Award

Padma Ladda
Affiliation Appasaheb Birnale College of Pharmacy, Sangli
Country India
Google Scholar ID 6ZyI9VYAAAAJ
Citations 243
h-index 8
i10-index 5
Article Research Paper
Publication Year 2026
Article Views 109
Reference Count 55
Subject Area Pharmacological Screening
Event Indian Scientist Awards
DOI 10.33899/iraqij.p.2026.174043.1290

Padma Ladda

Padma Ladda is a researcher affiliated with Appasaheb Birnale College of Pharmacy, Sangli, India. Her academic profile includes research in pharmacological screening, central nervous system (CNS) research and tuberculosis (TB). Her scholarly record includes an article published in the Iraqi Journal of Pharmacy in 2026, alongside the supplied Google Scholar citation metrics. [1] [2]

Abstract

Padma Ladda is a researcher affiliated with Appasaheb Birnale College of Pharmacy, Sangli, India. Her academic interests include pharmacological screening, central nervous system research and tuberculosis. Her research record includes a 2026 article in the Iraqi Journal of Pharmacy, with an associated DOI and reported Google Scholar indicators reflecting scholarly publication and citation activity. [1] [2]

Keywords

Pharmaceutical Research; Pharmacological Screening; Central Nervous System; CNS Research; Tuberculosis; TB Research; Research Publications; Citation Analysis; Academic Research; Pharmaceutical Sciences; Indian Scientist Awards.

Introduction

Pharmaceutical research contributes to understanding drug activity, therapeutic possibilities and disease-related mechanisms. Pharmacological screening, central nervous system studies and tuberculosis research represent important areas within pharmaceutical sciences. Padma Ladda’s academic profile is associated with these subject areas and Appasaheb Birnale College of Pharmacy, Sangli, reflecting her engagement with pharmaceutical research. [1]

Research Profile

Padma Ladda is affiliated with Appasaheb Birnale College of Pharmacy, Sangli, India. Her identified research interests encompass pharmacological screening, central nervous system studies and tuberculosis. Her Google Scholar profile reports 243 citations, an h-index of 8 and an i10-index of 5, providing bibliometric indicators of her scholarly research activity. [1] [2]

Research Contributions

Her research interests cover pharmacological screening and selected areas of pharmaceutical investigation, including CNS-related studies and tuberculosis. These disciplines involve evaluating biological responses, exploring therapeutic approaches and examining disease-related processes. Her academic contributions can be assessed through published research outputs, their scientific methodology and their relevance to ongoing developments in pharmaceutical sciences. [1] [3]

Publications

The supplied publication record identifies a research paper by Padma Ladda in the Iraqi Journal of Pharmacy, published in 2026. The article is associated with DOI 10.33899/iraqij.p.2026.174043.1290 and has a reported reference count of 55 and 109 article views. These details provide identifiable publication information for scholarly verification. [3]

Research Impact

The supplied Google Scholar profile records 243 citations, an h-index of 8 and an i10-index of 5 for Padma Ladda. These bibliometric measures provide quantitative information about publication visibility and citation activity. Together with her identified journal publication, the indicators offer a useful basis for reviewing her scholarly engagement and academic research profile. [1] [2]

Award Suitability

The Best Research Article Award recognizes scholarly publication and research contributions supported by identifiable academic records. Padma Ladda’s 2026 journal article, DOI information and reported citation indicators provide relevant material for consideration. Her research interests in pharmacological screening, CNS and tuberculosis further establish the academic context of her profile under the Indian Scientist Awards programme. [1] [3]

Conclusion

Padma Ladda’s academic profile reflects engagement with pharmaceutical research through identified subject interests and journal publication activity. Her 2026 research article and reported Google Scholar metrics provide useful indicators for evaluating her scholarly record. The Best Research Article Award acknowledges the relevance of documented publication activity within the Indian Scientist Awards recognition framework. [1] [3]

References

  1. Google Scholar. (n.d.). Author profile: Padma Ladda, Google Scholar ID 6ZyI9VYAAAAJ. Google Scholar.

    https://scholar.google.com/citations?user=6ZyI9VYAAAAJ&hl=en

  2. Iraqi Journal of Pharmacy. (2026). Research article associated with DOI 10.33899/iraqij.p.2026.174043.1290. Iraqi Journal of Pharmacy.

    https://doi.org/10.33899/iraqij.p.2026.174043.1290

  3. Indian Scientist Awards. (n.d.). Official award programme website.

    https://indianscientist.in/

Tapas Sar | Pharmacology | Pioneer Researcher Award

Prof. Tapas Sar | Pharmacology | Pioneer Researcher Award

West Bengal University of Animal and Fishery Sciences, India

Author Profile

SCOPUS

🎓 EARLY ACADEMIC PURSUITS

Dr. Tapas Kumar Sar demonstrated academic brilliance from an early age, earning National Scholarships from Class VIII through his undergraduate education. He completed his Bachelor’s in Veterinary Science and Animal Husbandry (BVSc&AH) in 1997, followed by a Master’s (M.V.Sc.) in Veterinary Pharmacology & Toxicology in 2000. His Ph.D. (2004) at West Bengal University of Animal and Fishery Sciences focused on the disposition kinetics of ceftriaxone in goats, including interactions with herbal drugs like Fibrosin®. He qualified NET in 2001, showcasing his foundational excellence in veterinary pharmacology.

🏢 PROFESSIONAL ENDEAVORS

Dr. Sar’s professional journey spans over 25 years in Veterinary Pharmacology and Toxicology. Starting as a Lecturer and rising to Professor at West Bengal University of Animal and Fishery Sciences, he has contributed extensively in teaching, research, and mentoring. He has also worked with Birsa Agricultural University, Amrit Feeds Ltd., and Shalimar Hatcheries Ltd., combining academic leadership with industrial insight.

  • Guided 6 Ph.D. and 10 Master’s scholars

  • Major advisory role in postgraduate committees

  • Taught and mentored veterinary science students since 2007

📚 CONTRIBUTIONS AND RESEARCH FOCUS IN PHARMACOLOGY

Dr. Sar has specialized in toxicokinetics, pharmacokinetics, and drug-herb interactions with an emphasis on antibiotic resistance, mastitis therapy, and environmental toxicology in livestock.

Key Areas:

  • Pharmacokinetics of antibiotics (Ceftriaxone, Ceftizoxime)

  • Herbal-drug interactions and complementary therapies

  • Residue monitoring in milk and meat

  • Development of safer alternatives to combat antimicrobial resistance (AMR)

  • Toxicokinetics of environmental pollutants (pesticides, herbicides)

🏅 ACADEMIC CITATIONS, ACCOLADES AND RECOGNITION

Dr. Sar has published over 40+ high-impact research papers, with citations in Scopus, PubMed, and Web of Science-indexed journals like:

  • Journal of Agricultural & Food Chemistry (ACS)

  • Scientific Reports (Nature Group)

  • Phytomedicine Plus (Elsevier)

  • The Veterinary Journal

  • Letters in Applied Microbiology

📘 Books & Chapters:

  • Editor and contributor to “Mastitis: Symptoms, Triggers and Treatments” (Nova Science, USA)

  • Chapters in Veterinary Pharmacology & Toxicology (Kalyani Publishers)

🏅 Recognitions:

  • World Research Fellow – London (2025)

  • India’s Best Doctor Award – Medical Innovation (2025)

  • Young Scientist Award (2002, 2017)

  • Best Faculty Award – IPS WB Branch

  • Best Research Presentation Awards – Multiple Conferences

🌍 IMPACT AND INFLUENCE

His work has not only contributed academically but also influenced policy, animal health practices, and antimicrobial stewardship. Dr. Sar’s studies have been featured in global surveillance platforms like:

  • Stewardship/Resistance Scan (2018)

  • ASP Scan Weekly (2018)

His innovative use of polyherbal drugs to mitigate AMR has been a paradigm shift in sustainable veterinary practices.

🧭 LEGACY AND FUTURE CONTRIBUTIONS

With two patents (GoI) under processing and a German utility patent granted in 2022, Dr. Sar continues to innovate in:

  • Herbal therapeutic development

  • Veterinary drug safety protocols

  • Eco-friendly antimicrobial strategies

As a Bentham Science Ambassador, Associate Editor, and active editorial board member, he fosters global scholarly collaboration and mentors future pharmacologists.

 ✅CONCLUSION

Dr. Tapas Kumar Sar stands as a veteran scholar, impactful researcher, and visionary educator in veterinary pharmacology. His pioneering work on herbal drug interactions, AMR reduction, and livestock toxicology has left a lasting impression on both national and international veterinary science communities. His academic rigor, innovative outlook, and societal contributions make him a torchbearer of pharmacological excellence and sustainable animal health.

🔬NOTABLE PUBLICATION:

Pharmacokinetics and residues of florfenicol in Nile tilapia (Oreochromis niloticus) post‑oral gavage
Authors: Avishek Bardhan, Thangapalam Jawahar Abraham, Tapas Kumar Sar, Ravindran Rajisha, Satyen Kumar Panda, Prasanna Kumar Patil
Journal: Environmental Toxicology and Pharmacology
Year: 2024

Raw Ocimum sanctum L. leaf extract modulates the pharmacokinetic of ceftriaxone and increases its bioavailability in staphylococcal mastitis
Authors: Jeevan Ranjan Dash, Tapas Kumar Sar, Indranil Samanta, Tapan Kumar Mandal
Journal: Indian Journal of Pharmacology
Year: 2024

Histopathological aberrations and oxidative stress responses in Nile tilapia (Oreochromis niloticus) as influenced by dietary florfenicol and its metabolites
Authors: Avishek Bardhan, Thangapalam Jawahar Abraham, Jasmine Singha, Tapas Kumar Sar, Ravindran Rajisha, Edaparambil Krishnappan Nanitha Krishna, Kesavan Ashok Kumar, Prasanna Kumar Patil
Journal: Aquaculture
Year: 2022

Enhanced plasma persistence of ceftriaxone following single intramuscular injection with prior oral dosing of a mammary protective commercial herbal drug as complementary therapy
Authors: Tapas Kumar Sar, Rinku Buragohain, Rabindra Nath Hansda, Tapan Kumar Mandal
Journal: Phytomedicine Plus
Year: 2022